Shopping Cart
- Remove All
- Your shopping cart is currently empty
Montelukast dicyclohexylamine (MK0476), a potent, selective, and orally active antagonist of the cysteinyl leukotriene receptor 1 (CysLT1), is utilized in the research of asthma, liver injury, and COVID-19. It exhibits antioxidant properties in the context of intestinal ischemia-reperfusion injury and can mitigate cardiac damage. Additionally, it reduces eosinophil infiltration in the airways of asthmatic patients.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.586 € | 1-2 weeks | |
50 mg | 2.071 € | 1-2 weeks | |
100 mg | 2.660 € | 1-2 weeks |
Description | Montelukast dicyclohexylamine (MK0476), a potent, selective, and orally active antagonist of the cysteinyl leukotriene receptor 1 (CysLT1), is utilized in the research of asthma, liver injury, and COVID-19. It exhibits antioxidant properties in the context of intestinal ischemia-reperfusion injury and can mitigate cardiac damage. Additionally, it reduces eosinophil infiltration in the airways of asthmatic patients. |
Alias | MK0476 dicyclohexylamine |
Molecular Weight | 767.5 |
Formula | C47H59ClN2O3S |
Cas No. | 577953-88-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.